Shares of Bluejay Diagnostics Inc (NASDAQ:BJDX) surged 110% in premarket trading on Thursday after the medical diagnostics firm announced it had expanded its manufacturing partnership with SanyoSeiko Co., Ltd. of Japan.
The company, which develops rapid testing solutions for near-patient diagnostics, said it had amended its Master Service and Master Supply Agreements with SanyoSeiko to significantly broaden the partner’s role in the commercialization of its Symphony platform.
Under the revised deal, SanyoSeiko will now oversee a wide range of responsibilities including analyzer and cartridge redevelopment, raw material procurement, and serving as Bluejay’s contract manufacturing organization. The Japanese firm will also manage fulfillment, kit assembly, labeling, packaging, shipping, and quality control.
The Symphony platform aims to provide fast and reliable biomarker readings, including IL-6 levels, which are critical in sepsis management and other acute care settings.
“This expanded partnership marks a key milestone in Bluejay’s commercialization strategy for the Symphony platform,” said Neil Dey, CEO of Bluejay. “By formalizing SanyoSeiko’s role as manufacturing partner, we strengthen our supply chain resilience, secures high-quality production capacity, and advances readiness for broader clinical validation and market introduction.”
Futoshi Shirakawa, CEO of SanyoSeiko, added that the company’s “technical capabilities and manufacturing experience will support the successful commercialization of Symphony, a platform with the potential to make a meaningful impact in critical care diagnostics worldwide.”
Bluejay Diagnostics stock price
This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.